BCL2 and neoplasm: When DNA repair fails, tumor cells can evade apoptosis, often through upregulation of the anti‐apoptotic protein Bcl‐2 and downregulation of the pro‐apoptotic protein BAX.[11, 12] Targeting the BAX/Bcl‐2 pathway has been shown to enhance tumor radiosensitivity.